Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-18

FDA Approved: APADAZ — Supplemental Application (Zevra Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for APADAZ (benzhydrocodone and acetaminophen) from Zevra Therapeutics, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • APADAZ (Benzhydrocodone and acetaminophen)

Snippet

SUPPL AP for APADAZ (BENZHYDROCODONE AND ACETAMINOPHEN)